News

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...
With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
The Trump administration said it was cancelling $766 million in funding for a Moderna vaccine contract that was supposed to help pay for the development of a shot that would protect people against ...